What is the main business of Gazolina-Med?

The main business activity of Gazolina-Med focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 28, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Jagiellońska 7, 14-220 Kisielice.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $3,749, representing an increase of 27.9% compared to 2024.

No, in 2025 the company was not profitable, reporting a net loss of $4,793. For comparison, in 2024 the loss was $7,967, meaning the company reduced its loss by 40.0%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $3,693 in 2025, representing 43% of all operating expenses.

Gazolina-Medsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-09-28

Share capital

5,000.00 PLN

Registered address

ul. Jagiellońska 7, 14-220 Kisielice, Poland

Electronic delivery address

AE:PL-84779-84744-IVWIW-25

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 95 days for 2021).

202513/03/2026
202413/03/2025
202309/08/2024
202228/07/2023
202118/10/2022
202018/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.75kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -4.79kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 8.54kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 979.44MedianUSD 883.09kAverageUSD 31.39m

Industry

Trademarks

Gazolina-Med holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.

Mark	Number	Classes	Status	Protected until
Hemorex sztyft na hemoroidy	Z.572117	5	Protected	Jul 18, 2034

Mark	Protected until
Hemorex sztyft na hemoroidy	Jul 18, 2034

Authorized Representatives

Julia Anna Dybich – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Julia Anna Dybichage 26	92	$1,242.57	92%
Others	8	$108.05	8%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-01-21.

Bank Millennium
33 1160 2202 0000 0004 7732 9450

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
F1 PharmaS.A.	$272,113.66	f1pharma.pl
Ti-Comsp. z o.o.	$157,549.77	ticomglobal.com
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com